22nd century group inc. (XXII)

22nd Century Group, Inc. (XXII), Tuesday announced submission of public comments in support of the FDA's proposed "Tobacco Product Standard for Nicotine Yield of Cigarettes and Certain Other Combusted Tobacco Products." The submission underscores clear and consistent acknowledgement among medical...

22nd Century Group, Inc. (XXII) surged 5.45 percent to $4.83 as the company highlighted expanding adoption of its VLN reduced nicotine content cigarettes by additional tobacco brands.

22nd Century Group Inc. (XXII) announced Loss for first quarter of -$4.328 million The company's earnings totaled -$4.328 million, or -$2.50 per share. This compares with -$9.328 million, or -$395.07 per share, last year. The company's revenue for the period fell 7.9% to $5.956 million from $6.469...

22nd Century Group, Inc. (XXII), a next-generation plant biotechnology company, was featured in a Washington Post article on Tuesday, discussing the U.S. FDA's proposed policy to reduce nicotine content in cigarettes. The policy, which recently passed a review by the Office of Management and Budget,...

Shares of 22nd Century Group, Inc. (XXII) are up 102% on Friday following the announcement of a new contract manufacturing agreement for branded conventional cigarette products. XXII is trading on the Nasdaq at $2.86, up 93.58% or $1.38 per share. It has traded between $1.62 and $3.68 in the past...